Correlation Between Day One and Elevation Oncology

Can any of the company-specific risk be diversified away by investing in both Day One and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Day One and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Elevation Oncology.

Diversification Opportunities for Day One and Elevation Oncology

0.02

Correlation Coefficient

Day One  Elevation Oncology

Significant diversification

The 3 months correlation between Day and Elevation is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Day One i.e., Day One and Elevation Oncology go up and down completely randomly.

Pair Corralation between Day One and Elevation Oncology

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.9 times less risky than Elevation Oncology. The stock trades about -0.07 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  60.00  in Elevation Oncology on August 31, 2024 and sell it today you would earn a total of  2.00  from holding Elevation Oncology or generate 3.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Elevation Oncology

Day One Biopharmaceu

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Elevation Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Day One and Elevation Oncology

The main advantage of trading using opposite Day One and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.

The idea behind Day One Biopharmaceuticals and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.